ArticleNeurourology and urodynamics2018
Phenotyping the detrusor underactivity: Is it more important than categorizing the symptomatic presentation of detrusor underactivity?
Article in Neurourology and urodynamics, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
- Comment on
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
aimsRecently, [Brown et al Neurourol Urodyn. 36:1151-1154, 2017] reported a remarkable study regarding detrusor underactivity (DU) by categorizing the possible phenotypes. Although this study presents novel findings on the possible phenotypes, several points need to be clarified further for a better understanding.
methodsThe methodology, especially regarding categorizing the phenotypes has been reviewed and comments have been added for better understanding of their study.
resultsTo better understand novel results of their study, several points have to be considered, which include cluster analysis and categorization according to symptomatic presentations.
conclusionsPhenotyping by either etiologies or covariates and by syndromic presentations is not easy. Due to the aging features, multiple factors are needed during interpretation of the categorized phenotypes. Considering the advantage of the clinical benefit from the patient's viewpoint, categorization of syndromic symptomatic presentation using multiple validated tools including patient-reported outcomes is needed.
Indexed as
Identifiers
29214675What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.